Chargement en cours...
PARP Inhibitors: The First Synthetic Lethal Targeted Therapy
PARP inhibitors (PARPi), a cancer therapy targeting poly(ADP-ribose) polymerase, are the first clinically approved drugs designed to exploit synthetic lethality, a genetic concept proposed nearly a century ago. Tumors arising in patients who carry germline mutations in either BRCA1 or BRCA2 are sens...
Enregistré dans:
| Publié dans: | Science |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6175050/ https://ncbi.nlm.nih.gov/pubmed/28302823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aam7344 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|